New number of shares and votes in BioGaia AB (publ)

The number of shares and votes in BioGaia has increased during May due to the share split resolved by BioGaia’s Annual General Meeting on 6 May 2022, whereby each existing share, regardless of series, was divided into five new shares.

As of 31 May 2022, the total number of shares in BioGaia amounts to 100,982,310 (previously 20,196,462 shares), whereof 3,703,340 A shares, with ten votes each, and 97,278,970 B shares, with one vote each, corresponding to in total 134,312,370 votes. The share capital is unchanged and amounts to SEK 20,196,462.

As of 31 May 2022, BioGaia holds no treasury shares.

Latest press releases from BioGaia:

17.05.2022 BioGaia starts its own distribution in Canada
11.05.2022 BioGaia® Osfortis® winner of NutraIngredients Awards 2022
06.05.2022 Record date for share split in BioGaia AB (publ) determined as 19 May 2022

This disclosure contains information that BioGaia is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 31-05-2022 08:00 CET.

For more information, please contact

Isabelle Ducellier, CEO: +46 8 555 293 00
Alexander Kotsinas, CFO: +46 8 555 293 00
Marika Isberg, Executive Vice President: +46 8 555 293 00
 

BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in more than 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaia.com